Actuate Therapeutics, Inc. (ACTU)
NASDAQ: ACTU · Real-Time Price · USD
7.35
0.00 (0.00%)
Dec 5, 2025, 4:00 PM EST - Market closed
Actuate Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 |
| Selling, General & Admin | 12.52 | 6.48 | 3.27 | 3.82 |
| Research & Development | 11.85 | 18.68 | 21.71 | 16.39 |
| Operating Expenses | 24.37 | 25.16 | 24.97 | 20.21 |
| Operating Income | -24.37 | -25.16 | -24.97 | -20.21 |
| Interest Expense | -0.02 | -0.02 | -0.04 | -0.02 |
| Interest & Investment Income | 0.27 | 0.22 | 0.35 | 0.03 |
| Other Non Operating Income (Expenses) | - | -0.08 | -0.08 | 0.04 |
| EBT Excluding Unusual Items | -24.12 | -25.04 | -24.74 | -20.16 |
| Other Unusual Items | - | -2.25 | - | - |
| Pretax Income | -24.12 | -27.29 | -24.74 | -20.16 |
| Net Income | -24.12 | -27.29 | -24.74 | -20.16 |
| Net Income to Common | -24.12 | -27.29 | -24.74 | -20.16 |
| Shares Outstanding (Basic) | 20 | 8 | 1 | 1 |
| Shares Outstanding (Diluted) | 20 | 8 | 1 | 1 |
| Shares Change (YoY) | 418.68% | 483.48% | 18.54% | - |
| EPS (Basic) | -1.20 | -3.26 | -17.24 | -16.65 |
| EPS (Diluted) | -1.20 | -3.26 | -17.24 | -16.65 |
| EBIT | -24.37 | -25.16 | -24.97 | -20.21 |
Source: S&P Capital IQ. Standard template.
Financial Sources.